Chalada Suebsuwong

Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1

Malek Najjar, Chalada Suebsuwong, Soumya S. Ray et al. · Cell Reports · 2015 · 137 citations · Full text

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors

Peter Canning, Qui Ruan, Tobias Schwerd et al. · Chemistry & Biology · 2015 · 117 citations · Full text

Small molecule inhibitors reveal an indispensable scaffolding role of <scp>RIPK</scp> 2 in <scp>NOD</scp> 2 signaling

Matouš Hrdinka, Lisa Schlicher, Bing Dai et al. · The EMBO Journal · 2018 · 74 citations · Full text

Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors

Courtney Ackeifi, Ethan Swartz, Kunal Kumar et al. · JCI Insight · 2019 · 55 citations · Full text

Small Molecule Inhibitors, Dual Specificity, Molecular Regulation +18

Synthesis, in Vitro Evaluation and Cocrystal Structure of 4-Oxo-[1]benzopyrano[4,3-<i>c</i>]pyrazole<i>Cryptosporidium parvum</i>Inosine 5′-Monophosphate Dehydrogenase (<i>Cp</i>IMPDH) Inhibitors

Zhuming Sun, Jihan Khan, M. Makowska-Grzyska et al. · Journal of Medicinal Chemistry · 2014 · 32 citations · Full text